Merkel Cell Carcinoma - 28 Studies Found
Completed |
: Oblimersen in Treating Patients With Merkel Cell Carcinoma :
|
Completed |
: BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors :
|
Not yet recruiting |
: Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers :
|
Completed |
: Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors :
|
RECRUITING |
: Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer : Merkel Cell Carcinoma : 2024-05-09 : Pembrolizumab 400mg IV |
RECRUITING |
: Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma : Merkel Cell Carcinoma : 2024-05-09 : 400mg IV |
RECRUITING |
: Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma : Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8 : 2024-05-09 : Undergo tumor biopsy |